Tocainide analogues binding to human serum albumin: A HPLAC and circular dichroism study

Journal of Pharmaceutical and Biomedical Analysis

Volumn 53, Issue 2, 2010, Pages 179-185

  Pistolozzi, Marco ^a   Franchini, Carlo ^b   Corbo, Filomena ^b   Muraglia, Marilena ^b   De Giorgi, Marcella ^b   Felix, Guy ^c   Bertucci, C ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

Circular dichroism; Drug protein binding; High performance liquid affinity chromatography; Human serum albumin; Tocainide analogues

Indexed keywords

HUMAN SERUM ALBUMIN; TOCAINIDE; PROTEIN BINDING; SERUM ALBUMIN;

ARTICLE; BINDING AFFINITY; BINDING SITE; CIRCULAR DICHROISM; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID AFFINITY CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; DRUG EFFECTS; EVALUATION STUDY; HUMAN; METABOLISM; PROCEDURES;

BINDING SITES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCULAR DICHROISM; HUMANS; PROTEIN BINDING; SERUM ALBUMIN; TOCAINIDE;

EID: 77953488971     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.03.005     Document Type: Article

References (24)

1. Kerns E.H., Di L. Pharmaceutical profiling in drug discovery. Drug Discov. Today 2003, 8:316-323.
2. Peters T. All About Albumin: Biochemistry, Genetics and Medical Application 1996, Academic Press, New York.
3. Puniani T.S., Bertorini T.E. Tocainide therapy in muscle cramps and spasms due to neuromuscular disease. Muscle Nerve 1991, 14:280-285.
4. Franchini C., Corbo F., Lentini G., Bruno G., Scilimati A., Tortorella V., Conte Camerino D., De Luca A. Synthesis of new 2,6-prolylxylidide analogues of tocainide as stereoselective blockers of voltage-gated Na(+) channels with increased potency and improved use-dependent activity. J. Med. Chem. 2000, 43:3792-3798.
5. Franchini C., Carocci A., Catalano A., Cavalluzzi M.M., Corbo F., Lentini G., Scilimati A., Tortorella P., Conte Camerino D., De Luca A. Optically active mexiletine analogues as stereoselective blockers of voltage-gated Na(+) channels. J. Med. Chem. 2003, 46:5238-5248.
6. Muraglia M., Franchini C., Corbo F., Scilimati A., Sinicropi M.S., De Luca A., De Bellis M., Conte Camerino D., Tortorella V. Synthesis of beta-proline like derivatives and their evaluation as sodium channel blockers. J. Heterocyclic Chem. 2007, 44:1099-1103.
7. Catalano A., Carocci A., Corbo F., Franchini C., Muraglia M., Scilimati A., De Bellis M., De Luca A., Conte Camerino D., Sinicropi M.S., Tortorella V. Constrained analogues of tocainide as potent skeletal muscle sodium channel blockers towards the development of antimyotonic agents. Eur. J. Med. Chem. 2008, 43:2535-2540.
8. Carrieri A., Muraglia M., Corbo F., Pacifico C. 2D- and 3D-QSAR of tocainide and mexiletine analogues acting as Na(v)1.4 channel blockers. Eur. J. Med. Chem. 2009, 44:1477-1485.
9. Hille B. Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J. Gen. Physiol. 1977, 69:497-515.
10. Hage D.S. High-performance affinity chromatography: a powerful tool for studying serum protein binding. J. Chromatogr. B 2002, 768:3-30.
11. Bertucci C., Domenici E. Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance. Curr. Med. Chem. 2002, 9:1463-1481.
12. Kragh-Hansen U. Structure and ligand binding properties of human serum albumin. Dan. Med. Bull. 1990, 37:54-87.
13. Sudlow G., Birkett D.J., Wade D.N. The characterization of two specific drug binding sites on human serum albumin. Mol. Pharmacol. 1975, 11:824-832.
14. Still W.C., Kahn M., Mitra A. Rapid chromatographic technique for preparative separations with moderate resolution. J. Org. Chem. 1978, 43:2923-2925.
15. Terao Y., Kotaki H., Imai N., Achiwa K. Trifluoroacetic acid-catalyzed 1,3-cycloaddition of the simplest iminium ylide leading to 3-or 3,4-substituted pyrrolidines and 2,5-dihydropyrroles. Chem. Pharm. Bull. 1985, 33:2762-2766.
16. Bertucci C., Pistolozzi M., Felix G., Danielson U.H. HSA binding of HIV protease inhibitors: a high-performance affinity chromatography study. J. Sep. Sci. 2009, 32:1625-1631.
17. Aubry A.F., Markoglou N., Descorps V., Félix G., Wainer I.W. Evaluation of chiral stationary phases based on mixed immobilized proteins. J. Chromatogr. A 1994, 685:1-6.
18. Félix G., Descorps V. Stereochemical resolution of racemates, in HPLC, using a chiral stationary phase based upon immobilized α-chymotrypsin. I. Structural chiral separations. Chromatographia 1999, 49:595-605.
19. Noctor T.A.G., Diaz-Perez M.J., Wainer I.W. Use of a human serum albumin-based stationary phase for high-performance liquid chromatography as a tool for the rapid determination of drug-plasma protein binding. J. Pharm. Sci. 1993, 82:675-676.
20. Ascoli G.A., Bertucci C., Salvadori P. Ligand binding to a human serum albumin stationary phase: use of same-drug competition to discriminate pharmacologically relevant interactions. Biomed. Chromatogr. 1998, 12:248-254.
21. Yang J., Hage D.S. Role of binding capacity versus binding strength in the separation of chiral compounds on protein-based high-performance liquid chromatography columns. Interactions of d- and l-tryptophan with human serum albumin. J. Chromatogr. A 1996, 725:273-285.
22. The Pharmacological Basis of Therapeutics 1996, Mc Graw-Hill, New York. nineth ed. A. Goodman, A.G. Gilman (Eds.).
23. Urien S., Albengres E., Tillement J.P. Serum protein binding of valproic acid in healthy subjects and in patients with liver disease. Int. J. Clin. Pharmacol. Ter. Toxicol. 1981, 19:319-325.
24. Ascoli G.A., Domenici E., Bertucci C. Drug binding to human serum albumin: abridged review of results obtained with high-performance liquid chromatography and circular dichroism. Chirality 2006, 18:667-679.